LIVE Study: Evaluating Long Term Care Homes’ IntraVenous Therapy Experience

Aim: To develop and evaluate a clinical pathway that will support best practice of IV treatment delivery in long term care and avoid unnecessary emergency department transfers and hospitalizations.

Overview: Drs. Alexandra Papaioannou, Scientific Director of the GERAS Centre, Afeez Hazzan, postdoctoral fellow and George Ioannidis, GERAS Associate Scientific Director, will lead this year-long study that will be conducted in Hamilton and Grimsby with a team of interdisciplinary study partners including Medical Pharmacies Group Limited (MPGL), the Nurse-Led Outreach Team (NLOT), the HNHB Long-Term Care Council, Community Care Access Centre (CCAC), Behavioural Support Ontario (BSO), Emergency Medical Services (EMS), emergency department (ED) physicians, and geriatricians.

Summary: In Ontario, administration of IV therapy in long-term care (LTC) homes is fragmented due to poorly coordinated services among health care providers and a lack of an evidence-based pathway for the management of IV therapies.

Furthermore, IV therapy has traditionally been performed in controlled settings such as hospitals and emergency departments. This is costly and often results in unfavorable outcomes. The LIVE Study will assess resident, family caregiver, and key stakeholder’s (LTC staff, service partners) perceptions of a new clinical pathway for IV therapy in LTC homes.

LIVE Study partners have indicated their commitment to adopting the clinical pathway model in long term care homes across Ontario if the intervention for IV therapy proves to be successful.​

Learn more about this project from the video below.

Investigators